Skip to search formSkip to main contentSkip to account menu

EMD 55900

Known as: EMD 55 900, Mab 425 
A murine monoclonal antibody targeting the epidermal growth factor receptor (EGFR) exhibiting anti-tumor activity. EMD 55900 antibody binds to the… 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2004
2004
The murine IgG2a monoclonal antibody (mAb) EMD 55900 was produced against the human epidermoid carcinoma cell line A431, with… 
2003
2003
BACKGROUND Previously we demonstrated that the antitumor efficacy of monoclonal antibodies against the EGFR (epidermal growth… 
2002
2002
Recent studies demonstrated that tumors overexpressing the epidermal growth factor receptor (EGF‐R, erbB‐1) are associated with… 
2001
2001
Analysis of 1,060 xenotransplants derived from cancer cell lines as wel as spontaneously occurring tumors from the larynx… 
2001
2001
Analysis of 1060 xenotransplants derived from cancer cell lines as well as spontaneously occurring tumors from the larynx… 
1997
1997
EGF has been reported to stimulate thyroid cell proliferation. In the present study we investigated the effects of anti-EGF-R… 
1993
1993
SummaryWe recently described culture conditions that allow proliferation of metastatic human breast cancer cells from biopsy… 
1993
1993
Analyses of the level of expression of the epidermal growth factor receptor (EGF-R) of breast cancer tumors may add independent…